Editor’s reply to SmithBMJ 2013; 347 doi: https://doi.org/10.1136/bmj.f6859 (Published 19 November 2013) Cite this as: BMJ 2013;347:f6859
- Fiona Godlee, editor in chief1
- 1BMJ, BMA House, London WC1H 9JR, UK
Smith makes a good point.1 Like the tobacco industry the drug industry has repeatedly been found to have manipulated and suppressed research data to make its products seem better than they are. Non-industry funded research also suffers from such misconduct, but the scale and influence of pharma funded research make its current state of particular concern.
I am firmly of the view that clinical practice …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial